摘要
多民族精准用药水平关系到我国民族整体健康与民族团结,对实现《“健康中国2030”规划纲要》目标和我国发展安全至关重要。为提高多民族健康水平,本文以精准用药研究为核心,阐述其对提升用药合理性、安全性的重要性,强调少数民族精准用药研究的必要性,旨在建立基于多民族人群临床药动药效学变异因素的精准用药研究共识,以更好地保障不同民族人群用药疗效与安全。本共识系统梳理了多民族人群临床药动学及药效学变异概况,从遗传性因素、肠道菌群、病理生理状态、高原低氧环境、饮食习惯等显著影响因素,解析其导致药动药效学变异的原因及机制;并基于多民族人群临床药动学、药效学研究现有证据,以及最新研究技术(生理药动学虚拟人)和注意点阐明民族精准用药研究的价值和策略,经充分讨论达成共识,为多民族人群精准用药研究提供理论依据和实践指导。
The level of precision medication for multiple ethnic groups is crucial to the overall health and ethnic unity of our country,and is of vital importance to the realization of"Healthy China 2030"and the development and security of our country.To improve the health level of multiple ethnic groups,this article takes precision medication research as the core,elaborates on its significance in enhancing the rationality and safety of medication,and emphasizes the necessity of precision medication research for ethnic minorities.The aim is to establish a consensus on precision medication research based on the clinical pharmacokinetic and pharmacodynamic variations of multiple ethnic groups,in order to better ensure the efficacy and safety of medication for different ethnic groups.This consensus systematically reviews the general situation of clinical pharmacokinetic and pharmacodynamic variations in multiple ethnic groups,and analyzes the causes and mechanisms of variations from significant influencing factors such as genetic factors,intestinal flora,pathological and physiological states,high-altitude hypoxic environment,and dietary habits.Based on the existing evidence from clinical pharmacokinetics and pharmacodynamics studies of multi-ethnic populations,as well as the latest research techniques(physiologically pharmacokinetic virtual humans)strategies and considerations,the value and strategies of ethnic-specific drug use research are clarified.After thorough discussion,a consensus was reached,providing theoretical basis and practical guidance for the research on precise drug use in multi-ethnic populations.
作者
刘媛
崔诚
余淼
金文煜
白银亮
段雅彬
方草
贺建昌
何艳
黄桦
霍仕霞
金阳
姜林
姜哲
焦正
李学军
李向阳
李红健
刘丽宏
刘洋
丘宏强
孙凤
孙建军
王学昌
王建华
王振磊
魏世杰
颜晓文
张雷
张学农
张宇馨
赵军
尹继业
燕茹
王新春
刘东阳
LIU Yuan;CUI Cheng;YU Miao;JIN Wenyu;BAI Yinliang;DUAN Yabin;FANG Cao;HE Jianchang;HE Yan;HUANG Hua;HUO Shixia;JIN Yang;JIANG Lin;JIANG Zhe;JIAO Zheng;LI Xuejun;LI Xiangyang;LI Hongjian;LIU Lihong;LIU Yang;QIU Hongqiang;SUN Feng;SUN Jianjun;WANG Xuechang;WANG Jianhua;WANG Zhenlei;WEI Shijie;YAN Xiaowen;ZHANG Lei;ZHANG Xuenong;ZHANG Yuxin;ZHAO Jun;YIN Jiye;YAN Ru;WANG Xinchun;LIU Dongyang
出处
《中国临床药理学与治疗学》
北大核心
2026年第1期1-13,共13页
Chinese Journal of Clinical Pharmacology and Therapeutics
基金
国家自然科学基金(82173895,82574504)。
关键词
精准用药
多民族人群
药代动力学与药效学
影响因素
专家共识
precision medication
multiple ethnic groups
pharmacokinetics and pharmacodynamics
influencing factors
expert consensus
